---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

CEPI

🌎 cepi.net

CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership established in 2017 to accelerate the development of vaccines against future epidemics. It focuses on developing vaccines for various pathogens, including Ebola, Lassa virus, and COVID-19, and aims to compress vaccine development timelines to 100 days. CEPI also invests in platform technologies for rapid vaccine development and ensures fair allocation of vaccines worldwide through initiatives like COVAX.

---

CEPI - Latest News and Updates

• CEPI signed strategic agreements with Bio-Manguinhos to expand technological capabilities focusing on RNA and viral vector platforms.
• CEPI played a critical role in organizing and funding the Ebola vaccine clinical study 'Tujiokowe' in the Democratic Republic of the Congo, collaborating with partners like LSHTM and Wellcome Trust.
• CEPI is investing over $100 million in Nipah virus research, supporting vaccine development and collaborating with institutions in Bangladesh and Malaysia to enhance understanding of the virus.
• Nicole Lurie, executive director at CEPI, expressed concern over the lack of epidemiologic data and surveillance.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.